) has been revised to $7.65 / share. This is an increase of 12.50% from the prior estimate of $6.80 dated February 21, 2026. The price target is an average of many targets provided by analysts. The ...
) has been revised to $6.80 / share. This is a decrease of 11.11% from the prior estimate of $7.65 dated February 1, 2026. The price target is an average of many targets provided by analysts. The ...
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company ...
We recently compiled a list of the Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025. In this article, we are going to take a look at where Microbot Medical Inc (NASDAQ:MBOT) stands ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results